| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 93 | 2023 | 1265 | 5.650 |
Why?
|
| Cardiomyopathy, Dilated | 50 | 2023 | 851 | 4.710 |
Why?
|
| Sarcomeres | 39 | 2022 | 374 | 3.290 |
Why?
|
| Myosin Heavy Chains | 39 | 2022 | 414 | 2.670 |
Why?
|
| Myocardium | 84 | 2022 | 4776 | 2.620 |
Why?
|
| Cardiomyopathies | 28 | 2023 | 1912 | 2.350 |
Why?
|
| Heart Defects, Congenital | 38 | 2024 | 4584 | 2.110 |
Why?
|
| Mutation | 153 | 2024 | 29786 | 1.870 |
Why?
|
| Muscle Proteins | 17 | 2022 | 1159 | 1.750 |
Why?
|
| Mutation, Missense | 41 | 2023 | 2564 | 1.730 |
Why?
|
| Myocytes, Cardiac | 44 | 2024 | 1637 | 1.710 |
Why?
|
| Ventricular Myosins | 13 | 2018 | 50 | 1.610 |
Why?
|
| Myocardial Contraction | 33 | 2021 | 1585 | 1.510 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 13 | 2018 | 66 | 1.500 |
Why?
|
| T-Box Domain Proteins | 17 | 2022 | 471 | 1.420 |
Why?
|
| Heterozygote | 31 | 2021 | 2804 | 1.310 |
Why?
|
| RNA Splicing | 9 | 2023 | 907 | 1.250 |
Why?
|
| Multienzyme Complexes | 11 | 2008 | 686 | 1.160 |
Why?
|
| Heart | 35 | 2023 | 4467 | 1.160 |
Why?
|
| Induced Pluripotent Stem Cells | 16 | 2024 | 1736 | 1.130 |
Why?
|
| Cardiac Myosins | 9 | 2020 | 117 | 1.110 |
Why?
|
| Carrier Proteins | 32 | 2022 | 5021 | 1.110 |
Why?
|
| Heart Ventricles | 32 | 2023 | 3821 | 1.090 |
Why?
|
| RNA | 10 | 2023 | 2749 | 1.030 |
Why?
|
| Pedigree | 78 | 2023 | 4644 | 1.030 |
Why?
|
| Atrial Natriuretic Factor | 21 | 2012 | 393 | 1.010 |
Why?
|
| Twins, Monozygotic | 3 | 2021 | 458 | 1.000 |
Why?
|
| Genes | 62 | 2009 | 1893 | 0.940 |
Why?
|
| Mice | 251 | 2024 | 81183 | 0.930 |
Why?
|
| Trypan Blue | 1 | 2022 | 21 | 0.890 |
Why?
|
| Genetic Linkage | 44 | 2015 | 2421 | 0.890 |
Why?
|
| Lamin Type A | 4 | 2017 | 190 | 0.880 |
Why?
|
| Hearing Loss, Sensorineural | 11 | 2010 | 770 | 0.850 |
Why?
|
| Base Sequence | 97 | 2018 | 12797 | 0.840 |
Why?
|
| Chromosome Mapping | 53 | 2018 | 4740 | 0.830 |
Why?
|
| Sequence Analysis, RNA | 17 | 2022 | 2012 | 0.820 |
Why?
|
| Sucrose | 1 | 2022 | 164 | 0.820 |
Why?
|
| Animals | 308 | 2024 | 168757 | 0.820 |
Why?
|
| Myosins | 23 | 2019 | 409 | 0.820 |
Why?
|
| High-Throughput Nucleotide Sequencing | 15 | 2021 | 3597 | 0.790 |
Why?
|
| Solitary Nucleus | 1 | 2021 | 63 | 0.770 |
Why?
|
| Haploinsufficiency | 8 | 2021 | 328 | 0.770 |
Why?
|
| Genetic Variation | 28 | 2021 | 6544 | 0.760 |
Why?
|
| Chagas Disease | 4 | 2023 | 166 | 0.760 |
Why?
|
| Homeodomain Proteins | 20 | 2016 | 2421 | 0.760 |
Why?
|
| Trypanosoma cruzi | 4 | 2023 | 198 | 0.750 |
Why?
|
| Troponin T | 14 | 2022 | 754 | 0.730 |
Why?
|
| Calsequestrin | 6 | 2014 | 30 | 0.720 |
Why?
|
| Sequence Analysis, DNA | 18 | 2018 | 4803 | 0.700 |
Why?
|
| Exons | 11 | 2021 | 2437 | 0.690 |
Why?
|
| Calcium | 38 | 2021 | 5756 | 0.670 |
Why?
|
| Receptors, Antigen, T-Cell | 33 | 1994 | 2540 | 0.670 |
Why?
|
| Glycogen Storage Disease Type IIb | 5 | 2023 | 18 | 0.670 |
Why?
|
| H-2 Antigens | 19 | 1986 | 366 | 0.650 |
Why?
|
| Echocardiography | 26 | 2021 | 5102 | 0.650 |
Why?
|
| Epigenesis, Genetic | 7 | 2023 | 3647 | 0.640 |
Why?
|
| Bromodeoxyuridine | 2 | 2016 | 322 | 0.630 |
Why?
|
| Glycogen Storage Disease | 5 | 2007 | 41 | 0.630 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2023 | 72 | 0.630 |
Why?
|
| Disease Models, Animal | 44 | 2022 | 18029 | 0.600 |
Why?
|
| Genes, Dominant | 19 | 2016 | 880 | 0.600 |
Why?
|
| Cardiomegaly | 15 | 2023 | 620 | 0.600 |
Why?
|
| Lysosomes | 2 | 2023 | 893 | 0.590 |
Why?
|
| Gene Expression Regulation | 48 | 2021 | 12072 | 0.570 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2021 | 2268 | 0.570 |
Why?
|
| Gene Expression Profiling | 18 | 2020 | 9438 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 36 | 2021 | 17446 | 0.570 |
Why?
|
| Genes, MHC Class II | 18 | 1987 | 457 | 0.570 |
Why?
|
| Genetic Testing | 14 | 2019 | 3444 | 0.560 |
Why?
|
| Alleles | 28 | 2017 | 6933 | 0.560 |
Why?
|
| Ear, External | 3 | 2022 | 161 | 0.560 |
Why?
|
| Transcription Factors | 31 | 2022 | 12208 | 0.550 |
Why?
|
| Point Mutation | 17 | 2020 | 1623 | 0.550 |
Why?
|
| Phenotype | 63 | 2023 | 16365 | 0.550 |
Why?
|
| Humans | 368 | 2024 | 744343 | 0.550 |
Why?
|
| Founder Effect | 4 | 2022 | 189 | 0.540 |
Why?
|
| Fibrosis | 14 | 2023 | 2029 | 0.530 |
Why?
|
| Calcium-Binding Proteins | 10 | 2020 | 1081 | 0.530 |
Why?
|
| Protein Kinases | 8 | 2022 | 1640 | 0.510 |
Why?
|
| Gene Library | 5 | 2013 | 1074 | 0.510 |
Why?
|
| Steroid 21-Hydroxylase | 9 | 1992 | 34 | 0.510 |
Why?
|
| Heart Conduction System | 9 | 2017 | 1047 | 0.500 |
Why?
|
| Tropomyosin | 9 | 2010 | 102 | 0.490 |
Why?
|
| Troponin I | 10 | 2022 | 619 | 0.480 |
Why?
|
| Cell Nucleus | 4 | 2022 | 2969 | 0.480 |
Why?
|
| Myocardial Ischemia | 7 | 2021 | 2148 | 0.480 |
Why?
|
| Benzylamines | 4 | 2019 | 223 | 0.480 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 644 | 0.470 |
Why?
|
| Uracil | 4 | 2019 | 165 | 0.470 |
Why?
|
| Hypertrophy, Left Ventricular | 13 | 2021 | 859 | 0.470 |
Why?
|
| Gene Regulatory Networks | 8 | 2022 | 1708 | 0.460 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2010 | 176 | 0.460 |
Why?
|
| Mice, Transgenic | 44 | 2019 | 9734 | 0.450 |
Why?
|
| Microscopy, Fluorescence | 2 | 2021 | 2699 | 0.450 |
Why?
|
| Mice, Mutant Strains | 22 | 2017 | 1866 | 0.440 |
Why?
|
| RNA, Messenger | 48 | 2021 | 13033 | 0.440 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1990 | 0.430 |
Why?
|
| Peripartum Period | 3 | 2021 | 133 | 0.430 |
Why?
|
| Molecular Sequence Data | 66 | 2014 | 18111 | 0.430 |
Why?
|
| Genes, Mitochondrial | 1 | 2012 | 61 | 0.430 |
Why?
|
| Homozygote | 16 | 2017 | 1785 | 0.420 |
Why?
|
| GTP-Binding Proteins | 12 | 1997 | 970 | 0.420 |
Why?
|
| Genotype | 35 | 2023 | 12951 | 0.420 |
Why?
|
| Aortic Valve | 7 | 2019 | 1922 | 0.410 |
Why?
|
| Nucleic Acid Hybridization | 36 | 2009 | 1375 | 0.410 |
Why?
|
| T-Lymphocytes | 35 | 2016 | 10180 | 0.410 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.410 |
Why?
|
| AMP-Activated Protein Kinases | 12 | 2016 | 611 | 0.410 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2018 | 3617 | 0.400 |
Why?
|
| Abnormalities, Multiple | 10 | 2020 | 1416 | 0.400 |
Why?
|
| Male | 201 | 2023 | 350118 | 0.400 |
Why?
|
| Polymorphism, Genetic | 30 | 2006 | 4328 | 0.390 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 3 | 2022 | 161 | 0.390 |
Why?
|
| Tachycardia, Ventricular | 9 | 2014 | 1273 | 0.390 |
Why?
|
| Genome | 3 | 2022 | 1808 | 0.380 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 255 | 0.380 |
Why?
|
| Heart Failure | 18 | 2023 | 10900 | 0.370 |
Why?
|
| Amino Acid Sequence | 62 | 2018 | 13815 | 0.370 |
Why?
|
| Calcium Signaling | 7 | 2021 | 721 | 0.370 |
Why?
|
| Cloning, Molecular | 37 | 2000 | 4320 | 0.360 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 2009 | 28 | 0.360 |
Why?
|
| Deoxyribonucleases | 1 | 2011 | 214 | 0.350 |
Why?
|
| DNA, Complementary | 9 | 2022 | 2050 | 0.350 |
Why?
|
| Genomics | 10 | 2022 | 5720 | 0.350 |
Why?
|
| Immunoglobulin Light Chains | 15 | 1990 | 277 | 0.350 |
Why?
|
| Molecular Motor Proteins | 2 | 2007 | 107 | 0.350 |
Why?
|
| DNA | 62 | 2011 | 7301 | 0.340 |
Why?
|
| Genetic Techniques | 3 | 2011 | 435 | 0.340 |
Why?
|
| Mice, Knockout | 31 | 2020 | 14557 | 0.340 |
Why?
|
| Computational Biology | 3 | 2017 | 3521 | 0.330 |
Why?
|
| Female | 175 | 2023 | 380194 | 0.330 |
Why?
|
| Transcription, Genetic | 27 | 2020 | 7722 | 0.330 |
Why?
|
| Immunoglobulin kappa-Chains | 13 | 1981 | 173 | 0.330 |
Why?
|
| Pericardium | 4 | 2018 | 667 | 0.330 |
Why?
|
| Cells, Cultured | 23 | 2021 | 19229 | 0.330 |
Why?
|
| Genome, Human | 8 | 2020 | 4420 | 0.320 |
Why?
|
| Connexins | 3 | 2005 | 357 | 0.320 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2012 | 450 | 0.320 |
Why?
|
| Gene Frequency | 6 | 2023 | 3588 | 0.320 |
Why?
|
| DNA Copy Number Variations | 6 | 2022 | 1941 | 0.320 |
Why?
|
| Wolff-Parkinson-White Syndrome | 4 | 2003 | 117 | 0.320 |
Why?
|
| Major Histocompatibility Complex | 16 | 1991 | 936 | 0.310 |
Why?
|
| Receptors, Cell Surface | 11 | 2009 | 2866 | 0.310 |
Why?
|
| Vertigo | 1 | 2009 | 202 | 0.310 |
Why?
|
| Forelimb | 2 | 2005 | 122 | 0.310 |
Why?
|
| beta 2-Microglobulin | 8 | 1986 | 315 | 0.300 |
Why?
|
| Immunoglobulin J-Chains | 4 | 1996 | 27 | 0.300 |
Why?
|
| Adult | 99 | 2024 | 214055 | 0.300 |
Why?
|
| Catecholamines | 2 | 2009 | 387 | 0.300 |
Why?
|
| Sequence Deletion | 8 | 2018 | 1526 | 0.300 |
Why?
|
| Ventricular Remodeling | 7 | 2020 | 1224 | 0.300 |
Why?
|
| Steroid Hydroxylases | 7 | 1989 | 96 | 0.290 |
Why?
|
| Eustachian Tube | 1 | 2008 | 91 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2915 | 0.290 |
Why?
|
| Electrophysiology | 9 | 2007 | 1308 | 0.290 |
Why?
|
| Otitis Media with Effusion | 1 | 2008 | 114 | 0.290 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 3 | 2021 | 52 | 0.290 |
Why?
|
| GATA4 Transcription Factor | 2 | 2022 | 131 | 0.290 |
Why?
|
| Electrocardiography | 23 | 2020 | 6442 | 0.280 |
Why?
|
| Transfection | 21 | 1994 | 5892 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2023 | 2916 | 0.280 |
Why?
|
| Xenopus Proteins | 5 | 2002 | 433 | 0.280 |
Why?
|
| Calreticulin | 1 | 2007 | 98 | 0.280 |
Why?
|
| DNA Mutational Analysis | 22 | 2018 | 4186 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 1997 | 535 | 0.280 |
Why?
|
| Transforming Growth Factor beta | 3 | 2011 | 2007 | 0.280 |
Why?
|
| Glycogen | 6 | 2016 | 260 | 0.270 |
Why?
|
| Cell Proliferation | 8 | 2018 | 10481 | 0.270 |
Why?
|
| Child | 50 | 2023 | 77709 | 0.270 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2024 | 794 | 0.270 |
Why?
|
| Histones | 5 | 2023 | 2599 | 0.270 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2006 | 56 | 0.260 |
Why?
|
| Middle Aged | 83 | 2021 | 213383 | 0.260 |
Why?
|
| Ear, Middle | 1 | 2008 | 334 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2020 | 1541 | 0.260 |
Why?
|
| Adolescent | 56 | 2021 | 85781 | 0.260 |
Why?
|
| Dependovirus | 5 | 2016 | 706 | 0.260 |
Why?
|
| Trans-Activators | 6 | 2013 | 2924 | 0.260 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2183 | 0.260 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2024 | 142 | 0.260 |
Why?
|
| Software | 6 | 2020 | 4443 | 0.260 |
Why?
|
| Heart Arrest, Induced | 2 | 2018 | 355 | 0.260 |
Why?
|
| Lod Score | 14 | 2006 | 614 | 0.260 |
Why?
|
| Age of Onset | 13 | 2020 | 3271 | 0.250 |
Why?
|
| DNA Restriction Enzymes | 23 | 1987 | 570 | 0.250 |
Why?
|
| Recombination, Genetic | 26 | 2000 | 1586 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 20 | 2020 | 15519 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2020 | 373 | 0.240 |
Why?
|
| Cardiovascular System | 3 | 2022 | 832 | 0.240 |
Why?
|
| Sternum | 1 | 2005 | 177 | 0.240 |
Why?
|
| Hypertrophy | 3 | 2022 | 569 | 0.240 |
Why?
|
| Gene Expression | 11 | 2019 | 7799 | 0.240 |
Why?
|
| Gene Targeting | 4 | 2014 | 880 | 0.240 |
Why?
|
| Hypercalcemia | 4 | 1995 | 409 | 0.240 |
Why?
|
| Calcium Channel Blockers | 2 | 2010 | 690 | 0.240 |
Why?
|
| Proteins | 8 | 2024 | 6103 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2002 | 478 | 0.240 |
Why?
|
| Beta-Globulins | 5 | 1983 | 27 | 0.240 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 1997 | 139 | 0.230 |
Why?
|
| Penetrance | 7 | 2020 | 381 | 0.230 |
Why?
|
| Heart Block | 5 | 2016 | 410 | 0.230 |
Why?
|
| Nuclear Proteins | 7 | 2022 | 5853 | 0.230 |
Why?
|
| Morphogenesis | 3 | 2011 | 752 | 0.230 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 22 | 0.230 |
Why?
|
| DNA, Mitochondrial | 3 | 2022 | 817 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2018 | 713 | 0.230 |
Why?
|
| Neoplasms | 9 | 2022 | 21683 | 0.230 |
Why?
|
| Ventricular Dysfunction | 3 | 2011 | 143 | 0.230 |
Why?
|
| Diltiazem | 2 | 2010 | 133 | 0.230 |
Why?
|
| Amino Acid Substitution | 11 | 2014 | 1791 | 0.220 |
Why?
|
| Body Patterning | 2 | 2020 | 626 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 14 | 6 | 2000 | 299 | 0.220 |
Why?
|
| Models, Genetic | 7 | 2019 | 3494 | 0.220 |
Why?
|
| Heredity | 2 | 2020 | 154 | 0.220 |
Why?
|
| Verapamil | 3 | 2019 | 244 | 0.220 |
Why?
|
| Immunoglobulin A | 3 | 1996 | 992 | 0.220 |
Why?
|
| Micrognathism | 1 | 2022 | 57 | 0.210 |
Why?
|
| Goldenhar Syndrome | 1 | 2022 | 37 | 0.210 |
Why?
|
| MicroRNAs | 3 | 2013 | 3752 | 0.210 |
Why?
|
| Syndrome | 18 | 2013 | 3251 | 0.210 |
Why?
|
| Plakophilins | 1 | 2022 | 34 | 0.210 |
Why?
|
| Heart Rate | 10 | 2016 | 4091 | 0.210 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Genes, Neoplasm | 3 | 2021 | 376 | 0.210 |
Why?
|
| Mice, Inbred Strains | 13 | 2016 | 1827 | 0.210 |
Why?
|
| Dystrophin | 1 | 2023 | 285 | 0.210 |
Why?
|
| Congenital Abnormalities | 4 | 2015 | 707 | 0.210 |
Why?
|
| Heart Diseases | 4 | 2022 | 2788 | 0.210 |
Why?
|
| Fabry Disease | 2 | 2017 | 90 | 0.200 |
Why?
|
| Protein Biosynthesis | 12 | 2019 | 2126 | 0.200 |
Why?
|
| Child, Preschool | 26 | 2021 | 41006 | 0.200 |
Why?
|
| Immunoglobulin Variable Region | 11 | 1999 | 421 | 0.200 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2016 | 500 | 0.200 |
Why?
|
| Troponin | 7 | 2010 | 524 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 29 | 2020 | 21827 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 7 | 2016 | 342 | 0.200 |
Why?
|
| Haplotypes | 16 | 2020 | 2779 | 0.190 |
Why?
|
| Blotting, Northern | 10 | 2009 | 1581 | 0.190 |
Why?
|
| Protein Precursors | 6 | 1988 | 1154 | 0.190 |
Why?
|
| Aging | 8 | 2023 | 8664 | 0.190 |
Why?
|
| Endothelial Cells | 5 | 2024 | 3479 | 0.190 |
Why?
|
| Cell Separation | 4 | 2021 | 1751 | 0.190 |
Why?
|
| Poly U | 1 | 2020 | 10 | 0.190 |
Why?
|
| Poly G | 1 | 2020 | 7 | 0.190 |
Why?
|
| Aged | 53 | 2021 | 163280 | 0.190 |
Why?
|
| Heart Transplantation | 6 | 2023 | 3110 | 0.190 |
Why?
|
| GATA6 Transcription Factor | 1 | 2020 | 50 | 0.190 |
Why?
|
| Macromolecular Substances | 15 | 1995 | 1454 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 1999 | 326 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 2541 | 0.180 |
Why?
|
| Rats | 32 | 2019 | 24260 | 0.180 |
Why?
|
| Ventricular Function, Left | 7 | 2020 | 3670 | 0.180 |
Why?
|
| Heart Atria | 10 | 2020 | 1357 | 0.180 |
Why?
|
| Urea | 2 | 2019 | 450 | 0.180 |
Why?
|
| Actins | 9 | 2006 | 2121 | 0.180 |
Why?
|
| Repressor Proteins | 5 | 2023 | 3023 | 0.180 |
Why?
|
| Acetylation | 2 | 2021 | 1085 | 0.180 |
Why?
|
| Young Adult | 26 | 2023 | 56430 | 0.180 |
Why?
|
| Cell Line | 40 | 2016 | 15997 | 0.180 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 151 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2022 | 424 | 0.170 |
Why?
|
| Antigens, Surface | 11 | 1988 | 1663 | 0.170 |
Why?
|
| Potassium Channels | 3 | 2017 | 563 | 0.170 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 60 | 0.170 |
Why?
|
| Oligonucleotides | 2 | 2022 | 572 | 0.170 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 104 | 0.170 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 64 | 0.170 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 96 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 112 | 0.170 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 102 | 0.170 |
Why?
|
| CpG Islands | 2 | 2020 | 1172 | 0.170 |
Why?
|
| X Chromosome | 3 | 1999 | 814 | 0.170 |
Why?
|
| Paternal Age | 1 | 2019 | 84 | 0.170 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 12261 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 1997 | 798 | 0.170 |
Why?
|
| Signal Transduction | 17 | 2019 | 23403 | 0.170 |
Why?
|
| Extremities | 2 | 2024 | 865 | 0.170 |
Why?
|
| Sinoatrial Node | 2 | 2018 | 101 | 0.170 |
Why?
|
| Calcium Channels, L-Type | 2 | 2015 | 240 | 0.170 |
Why?
|
| Diaphragm | 1 | 2020 | 349 | 0.170 |
Why?
|
| Genes, Regulator | 3 | 1991 | 378 | 0.170 |
Why?
|
| Myeloma Proteins | 7 | 1981 | 72 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2023 | 1157 | 0.160 |
Why?
|
| Cerebrum | 1 | 2020 | 137 | 0.160 |
Why?
|
| Mosaicism | 2 | 2020 | 441 | 0.160 |
Why?
|
| Serum Response Factor | 1 | 2018 | 81 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2019 | 127 | 0.160 |
Why?
|
| Transgenes | 4 | 2017 | 1009 | 0.160 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 15165 | 0.160 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 1197 | 0.160 |
Why?
|
| Ear | 2 | 2022 | 173 | 0.160 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 127 | 0.160 |
Why?
|
| Adenosine Triphosphate | 5 | 2019 | 2025 | 0.160 |
Why?
|
| Coronary Artery Bypass | 4 | 2019 | 2289 | 0.160 |
Why?
|
| Genetic Association Studies | 6 | 2020 | 2703 | 0.160 |
Why?
|
| Cell-Matrix Junctions | 1 | 2018 | 23 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.160 |
Why?
|
| Stress, Physiological | 3 | 2018 | 1403 | 0.160 |
Why?
|
| Azepines | 1 | 2020 | 336 | 0.160 |
Why?
|
| Case-Control Studies | 13 | 2021 | 21746 | 0.160 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 336 | 0.160 |
Why?
|
| Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.160 |
Why?
|
| Blotting, Southern | 11 | 1996 | 803 | 0.160 |
Why?
|
| Genetic Counseling | 3 | 2014 | 600 | 0.160 |
Why?
|
| Gene Dosage | 3 | 2020 | 1252 | 0.160 |
Why?
|
| Systole | 7 | 2019 | 958 | 0.160 |
Why?
|
| Myofibrils | 3 | 2016 | 146 | 0.160 |
Why?
|
| Bone Development | 1 | 2001 | 483 | 0.160 |
Why?
|
| Calcineurin | 6 | 2016 | 226 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2018 | 1341 | 0.160 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 1997 | 249 | 0.160 |
Why?
|
| HEK293 Cells | 5 | 2019 | 4204 | 0.160 |
Why?
|
| Muscular Diseases | 3 | 2007 | 556 | 0.150 |
Why?
|
| Animals, Newborn | 9 | 2018 | 2726 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2011 | 476 | 0.150 |
Why?
|
| Interleukin-11 | 1 | 2017 | 63 | 0.150 |
Why?
|
| JC Virus | 1 | 2018 | 85 | 0.150 |
Why?
|
| Arrestins | 1 | 1997 | 74 | 0.150 |
Why?
|
| Thymidine Kinase | 3 | 1993 | 290 | 0.150 |
Why?
|
| Mice, 129 Strain | 2 | 2019 | 386 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2018 | 68 | 0.150 |
Why?
|
| Genetic Heterogeneity | 3 | 2014 | 733 | 0.150 |
Why?
|
| Immunoglobulin Constant Regions | 8 | 1986 | 59 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 1997 | 337 | 0.150 |
Why?
|
| Mutagenesis | 4 | 2018 | 1266 | 0.150 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 1423 | 0.150 |
Why?
|
| Proteoglycans | 3 | 2016 | 835 | 0.150 |
Why?
|
| Databases, Genetic | 4 | 2021 | 1783 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 12 | 2018 | 5867 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 118 | 0.150 |
Why?
|
| Antigens, CD | 3 | 2009 | 4026 | 0.150 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1620 | 0.150 |
Why?
|
| Cyclosporine | 5 | 2014 | 786 | 0.150 |
Why?
|
| Stem Cells | 5 | 2012 | 3567 | 0.150 |
Why?
|
| Cell Division | 2 | 2018 | 4568 | 0.150 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2016 | 314 | 0.150 |
Why?
|
| Secretory Component | 1 | 1996 | 16 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1997 | 246 | 0.150 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2010 | 789 | 0.150 |
Why?
|
| Actinin | 1 | 2018 | 160 | 0.150 |
Why?
|
| Cardiovascular Agents | 3 | 2019 | 850 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 3 | 2020 | 839 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 134 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2012 | 3523 | 0.140 |
Why?
|
| Anodontia | 3 | 2003 | 49 | 0.140 |
Why?
|
| Hyperparathyroidism | 3 | 1995 | 339 | 0.140 |
Why?
|
| Genetic Markers | 8 | 2014 | 2634 | 0.140 |
Why?
|
| Contractile Proteins | 3 | 2012 | 246 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 12 | 1994 | 805 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 453 | 0.140 |
Why?
|
| DNA Primers | 12 | 2009 | 2892 | 0.140 |
Why?
|
| Nucleotides | 2 | 2018 | 464 | 0.140 |
Why?
|
| Vestibule, Labyrinth | 1 | 1998 | 235 | 0.140 |
Why?
|
| Propranolol | 3 | 2019 | 502 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 5 | 2020 | 323 | 0.140 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 209 | 0.140 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2013 | 158 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 644 | 0.140 |
Why?
|
| Homeostasis | 9 | 2020 | 3340 | 0.140 |
Why?
|
| Gene Deletion | 5 | 2012 | 2751 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 3 | 2018 | 1965 | 0.140 |
Why?
|
| Hemodynamics | 4 | 2020 | 4199 | 0.140 |
Why?
|
| Infant | 17 | 2022 | 35136 | 0.140 |
Why?
|
| Thrombospondins | 1 | 2016 | 197 | 0.140 |
Why?
|
| Proteomics | 4 | 2023 | 3638 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2006 | 322 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 7 | 2015 | 658 | 0.130 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 535 | 0.130 |
Why?
|
| Calcium Channels | 2 | 2017 | 622 | 0.130 |
Why?
|
| RNA, Small Interfering | 4 | 2020 | 3505 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4838 | 0.130 |
Why?
|
| Immunoglobulins | 7 | 2015 | 881 | 0.130 |
Why?
|
| Models, Molecular | 7 | 2017 | 5456 | 0.130 |
Why?
|
| Myosin Subfragments | 3 | 1997 | 21 | 0.130 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1903 | 0.130 |
Why?
|
| Nucleic Acid Precursors | 5 | 1980 | 15 | 0.130 |
Why?
|
| Embryo, Mammalian | 7 | 2008 | 1701 | 0.130 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 299 | 0.130 |
Why?
|
| Restriction Mapping | 6 | 1995 | 878 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.130 |
Why?
|
| Lidocaine | 1 | 2018 | 544 | 0.130 |
Why?
|
| Pressure | 4 | 2019 | 1203 | 0.130 |
Why?
|
| Models, Biological | 8 | 2020 | 9583 | 0.130 |
Why?
|
| Genetic Vectors | 7 | 2016 | 3420 | 0.130 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 164 | 0.130 |
Why?
|
| Hand Deformities, Congenital | 2 | 2012 | 146 | 0.130 |
Why?
|
| Binding Sites, Antibody | 3 | 1980 | 349 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 513 | 0.130 |
Why?
|
| Hair | 1 | 1998 | 483 | 0.120 |
Why?
|
| Consanguinity | 2 | 2015 | 454 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 328 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.120 |
Why?
|
| Triazoles | 1 | 2020 | 911 | 0.120 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 707 | 0.120 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2014 | 17 | 0.120 |
Why?
|
| Inclusion Bodies | 1 | 1996 | 279 | 0.120 |
Why?
|
| DNA-Binding Proteins | 9 | 2019 | 9648 | 0.120 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 31 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2007 | 2839 | 0.120 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 211 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 1861 | 0.120 |
Why?
|
| Codon, Initiator | 1 | 2014 | 52 | 0.120 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1224 | 0.120 |
Why?
|
| Templates, Genetic | 2 | 2020 | 211 | 0.120 |
Why?
|
| Aorta | 3 | 2016 | 2061 | 0.120 |
Why?
|
| Acrosome | 1 | 1993 | 10 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 8 | 1989 | 1475 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 177 | 0.120 |
Why?
|
| Family Health | 5 | 2014 | 1282 | 0.120 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2014 | 174 | 0.120 |
Why?
|
| Apoptosis | 3 | 2014 | 9727 | 0.120 |
Why?
|
| DNA, Neoplasm | 6 | 2015 | 1758 | 0.120 |
Why?
|
| Sequence Alignment | 8 | 2013 | 2256 | 0.120 |
Why?
|
| Models, Cardiovascular | 5 | 2013 | 996 | 0.120 |
Why?
|
| Myocarditis | 2 | 2016 | 771 | 0.120 |
Why?
|
| Diaphyses | 1 | 2013 | 65 | 0.120 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 247 | 0.120 |
Why?
|
| Pancreas | 1 | 2020 | 1686 | 0.120 |
Why?
|
| Endocardial Cushions | 1 | 2013 | 13 | 0.120 |
Why?
|
| Chromatin | 6 | 2023 | 2934 | 0.110 |
Why?
|
| Disease Progression | 9 | 2015 | 13284 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2018 | 849 | 0.110 |
Why?
|
| Tricuspid Valve | 1 | 2016 | 403 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 374 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 1994 | 191 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2018 | 553 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2011 | 1152 | 0.110 |
Why?
|
| Flagella | 1 | 1993 | 103 | 0.110 |
Why?
|
| Atrioventricular Node | 2 | 2007 | 182 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 222 | 0.110 |
Why?
|
| Chickens | 5 | 2018 | 865 | 0.110 |
Why?
|
| Microscopy, Electron | 10 | 2007 | 2645 | 0.110 |
Why?
|
| Gene Rearrangement | 1 | 2018 | 1179 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 197 | 0.110 |
Why?
|
| Cell Differentiation | 15 | 2020 | 11483 | 0.110 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 57776 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2015 | 755 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 1213 | 0.110 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1994 | 211 | 0.110 |
Why?
|
| Receptors, Calcium-Sensing | 6 | 1998 | 315 | 0.110 |
Why?
|
| Fetal Development | 1 | 2018 | 767 | 0.110 |
Why?
|
| Algorithms | 4 | 2021 | 13881 | 0.110 |
Why?
|
| Muscle, Skeletal | 8 | 2020 | 4931 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 131 | 0.110 |
Why?
|
| Fetus | 2 | 2016 | 1880 | 0.110 |
Why?
|
| Protein Conformation | 6 | 2020 | 4011 | 0.110 |
Why?
|
| In Situ Hybridization | 6 | 2013 | 1950 | 0.110 |
Why?
|
| Genetics, Population | 2 | 2022 | 934 | 0.110 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 289 | 0.110 |
Why?
|
| Endonucleases | 2 | 2014 | 380 | 0.110 |
Why?
|
| Ubiquitins | 1 | 2014 | 384 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2023 | 2109 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2011 | 234 | 0.110 |
Why?
|
| RNA Interference | 3 | 2020 | 2889 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 243 | 0.100 |
Why?
|
| Crosses, Genetic | 6 | 2010 | 791 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 720 | 0.100 |
Why?
|
| Fibroblasts | 5 | 2024 | 4161 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2001 | 835 | 0.100 |
Why?
|
| Infant, Newborn | 10 | 2022 | 25625 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1157 | 0.100 |
Why?
|
| Adrenal Glands | 2 | 1992 | 546 | 0.100 |
Why?
|
| Osteopontin | 1 | 2013 | 296 | 0.100 |
Why?
|
| Genetic Structures | 1 | 2011 | 12 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2019 | 2585 | 0.100 |
Why?
|
| DNA Methylation | 3 | 2023 | 4286 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 4462 | 0.100 |
Why?
|
| Pigments, Biological | 1 | 1991 | 53 | 0.100 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2011 | 65 | 0.100 |
Why?
|
| Adrenal Cortex Neoplasms | 3 | 1990 | 162 | 0.100 |
Why?
|
| Laminin | 1 | 1993 | 419 | 0.100 |
Why?
|
| Testis | 2 | 1993 | 803 | 0.100 |
Why?
|
| Enchondromatosis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 816 | 0.100 |
Why?
|
| Molecular Probe Techniques | 2 | 2011 | 119 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 317 | 0.100 |
Why?
|
| Action Potentials | 3 | 2017 | 1806 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 452 | 0.100 |
Why?
|
| Brachyura | 1 | 2011 | 23 | 0.100 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2003 | 493 | 0.100 |
Why?
|
| Zebrafish | 4 | 2018 | 2994 | 0.100 |
Why?
|
| Muscular Dystrophies | 2 | 2013 | 393 | 0.100 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2011 | 29 | 0.100 |
Why?
|
| Genomic Library | 4 | 2009 | 193 | 0.100 |
Why?
|
| Molecular Conformation | 3 | 2006 | 563 | 0.100 |
Why?
|
| Plasmids | 7 | 1989 | 2307 | 0.100 |
Why?
|
| Myocardial Infarction | 6 | 2019 | 11727 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3305 | 0.100 |
Why?
|
| Tenosynovitis | 1 | 1991 | 57 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8428 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 1419 | 0.100 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2899 | 0.100 |
Why?
|
| Kinetics | 8 | 2021 | 6473 | 0.100 |
Why?
|
| Adrenal Cortex | 3 | 1988 | 140 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2010 | 41 | 0.100 |
Why?
|
| Proteome | 1 | 2021 | 1799 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 670 | 0.090 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 106 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 17 | 2011 | 6171 | 0.090 |
Why?
|
| Survival Analysis | 7 | 2018 | 10252 | 0.090 |
Why?
|
| Atrial Fibrillation | 5 | 2016 | 5034 | 0.090 |
Why?
|
| Peptide Fragments | 7 | 2010 | 5097 | 0.090 |
Why?
|
| Chediak-Higashi Syndrome | 1 | 1990 | 9 | 0.090 |
Why?
|
| Phosphorylation | 11 | 2015 | 8436 | 0.090 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2011 | 213 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 202 | 0.090 |
Why?
|
| Blood Pressure | 4 | 2011 | 8554 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2011 | 163 | 0.090 |
Why?
|
| Bacterial Proteins | 3 | 2014 | 3848 | 0.090 |
Why?
|
| Resistin | 1 | 2011 | 170 | 0.090 |
Why?
|
| Postprandial Period | 1 | 2011 | 292 | 0.090 |
Why?
|
| Binding Sites | 7 | 2020 | 6114 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 247 | 0.090 |
Why?
|
| Calcinosis | 2 | 2016 | 1499 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 122 | 0.090 |
Why?
|
| Procollagen | 1 | 2010 | 185 | 0.090 |
Why?
|
| Codon | 5 | 2019 | 611 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1344 | 0.090 |
Why?
|
| Mutant Proteins | 2 | 2015 | 500 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2000 | 380 | 0.090 |
Why?
|
| Ultrasonography | 7 | 2014 | 5985 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 2 | 2005 | 362 | 0.090 |
Why?
|
| DNA, Recombinant | 10 | 1988 | 476 | 0.090 |
Why?
|
| Lipase | 1 | 2011 | 314 | 0.090 |
Why?
|
| Simplexvirus | 1 | 1993 | 802 | 0.090 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1989 | 43 | 0.090 |
Why?
|
| Transformation, Genetic | 7 | 2002 | 192 | 0.090 |
Why?
|
| Myopathies, Nemaline | 1 | 2009 | 72 | 0.090 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 638 | 0.090 |
Why?
|
| Lymphocytes | 4 | 1996 | 2617 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 1 | 2008 | 40 | 0.090 |
Why?
|
| Spermatozoa | 1 | 1993 | 625 | 0.080 |
Why?
|
| Heart Valves | 1 | 2011 | 291 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2009 | 1185 | 0.080 |
Why?
|
| Chromosomes, Human, 6-12 and X | 2 | 1985 | 80 | 0.080 |
Why?
|
| Protein Subunits | 3 | 2011 | 959 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.080 |
Why?
|
| Complement C4 | 2 | 1992 | 257 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 1997 | 462 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1018 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2019 | 3537 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 151 | 0.080 |
Why?
|
| Zebrafish Proteins | 3 | 2016 | 1005 | 0.080 |
Why?
|
| Losartan | 1 | 2010 | 299 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1073 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2503 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Ouabain | 1 | 1988 | 264 | 0.080 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1992 | 222 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 296 | 0.080 |
Why?
|
| Fingers | 1 | 1991 | 513 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 10 | 2016 | 9274 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2020 | 810 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2016 | 281 | 0.080 |
Why?
|
| Magnesium | 2 | 2010 | 813 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1912 | 0.080 |
Why?
|
| Leukemia, Lymphoid | 5 | 1987 | 315 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2007 | 491 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2007 | 32 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1536 | 0.080 |
Why?
|
| Cohort Studies | 12 | 2020 | 40561 | 0.080 |
Why?
|
| Angiotensin II | 2 | 2023 | 881 | 0.080 |
Why?
|
| Blood Proteins | 1 | 1992 | 1124 | 0.080 |
Why?
|
| Avian Proteins | 2 | 1999 | 80 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2001 | 1085 | 0.080 |
Why?
|
| Iceland | 2 | 2020 | 183 | 0.080 |
Why?
|
| Lymphocyte Activation | 4 | 2003 | 5524 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 3 | 2014 | 418 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13695 | 0.070 |
Why?
|
| Prevalence | 7 | 2022 | 15226 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 2938 | 0.070 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 31 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 8 | 1987 | 1821 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2018 | 4217 | 0.070 |
Why?
|
| Lac Operon | 1 | 2007 | 238 | 0.070 |
Why?
|
| Tendons | 1 | 1991 | 548 | 0.070 |
Why?
|
| Limb Buds | 2 | 2024 | 77 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2013 | 1124 | 0.070 |
Why?
|
| Spermatocytes | 1 | 1986 | 42 | 0.070 |
Why?
|
| Clone Cells | 10 | 1994 | 1692 | 0.070 |
Why?
|
| Bartter Syndrome | 1 | 1986 | 24 | 0.070 |
Why?
|
| Parathyroid Glands | 4 | 1995 | 509 | 0.070 |
Why?
|
| Rats, Inbred SHR | 3 | 2011 | 195 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 337 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 643 | 0.070 |
Why?
|
| Hair Diseases | 1 | 2007 | 74 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2010 | 592 | 0.070 |
Why?
|
| Telemetry | 1 | 2007 | 205 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4751 | 0.070 |
Why?
|
| Time Factors | 12 | 2016 | 40075 | 0.070 |
Why?
|
| Cytokines | 2 | 2017 | 7322 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5655 | 0.070 |
Why?
|
| Leukemia, Experimental | 1 | 1986 | 246 | 0.070 |
Why?
|
| Diastole | 4 | 2007 | 791 | 0.070 |
Why?
|
| Epitopes | 11 | 1990 | 2571 | 0.070 |
Why?
|
| Hyperthyroidism | 1 | 1988 | 295 | 0.070 |
Why?
|
| Exercise Test | 2 | 2005 | 2074 | 0.070 |
Why?
|
| Genes, Immunoglobulin | 3 | 1995 | 291 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 5 | 2003 | 768 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1124 | 0.070 |
Why?
|
| Phospholipids | 1 | 1989 | 784 | 0.070 |
Why?
|
| Antibody Specificity | 6 | 1997 | 1095 | 0.070 |
Why?
|
| Hearing Loss | 1 | 2013 | 765 | 0.070 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 494 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 411 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 1998 | 403 | 0.070 |
Why?
|
| B-Lymphocytes | 8 | 1987 | 4665 | 0.070 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 2005 | 4 | 0.070 |
Why?
|
| Species Specificity | 7 | 2014 | 2478 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 4 | 2018 | 895 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2006 | 1246 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.070 |
Why?
|
| Veins | 2 | 2024 | 770 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2012 | 906 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2013 | 1114 | 0.070 |
Why?
|
| Age Factors | 9 | 2019 | 18370 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2015 | 367 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 8 | 1990 | 1369 | 0.060 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 203 | 0.060 |
Why?
|
| Peptides | 5 | 2011 | 4409 | 0.060 |
Why?
|
| Sirolimus | 2 | 2023 | 1564 | 0.060 |
Why?
|
| Metallothionein | 1 | 1985 | 59 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 1985 | 117 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2440 | 0.060 |
Why?
|
| Chromosomes | 4 | 1984 | 596 | 0.060 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2005 | 41 | 0.060 |
Why?
|
| Carpal Bones | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 15 | 1993 | 6386 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 686 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1573 | 0.060 |
Why?
|
| Tacrolimus | 2 | 2000 | 743 | 0.060 |
Why?
|
| Liver | 5 | 1995 | 7474 | 0.060 |
Why?
|
| Chromosome Disorders | 4 | 2013 | 514 | 0.060 |
Why?
|
| Natriuresis | 1 | 1984 | 124 | 0.060 |
Why?
|
| Jews | 2 | 1997 | 385 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2008 | 420 | 0.060 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2005 | 95 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2022 | 1338 | 0.060 |
Why?
|
| RNA, Transfer | 3 | 1975 | 316 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 2 | 2019 | 250 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 1526 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5751 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 195 | 0.060 |
Why?
|
| Ovalbumin | 3 | 2003 | 719 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.060 |
Why?
|
| Methylation | 3 | 2013 | 1106 | 0.060 |
Why?
|
| Tetralogy of Fallot | 1 | 2009 | 623 | 0.060 |
Why?
|
| Autophagy | 2 | 2022 | 1300 | 0.060 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2003 | 14 | 0.060 |
Why?
|
| Arm | 2 | 1997 | 589 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 3772 | 0.060 |
Why?
|
| Mesoderm | 2 | 2024 | 686 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 3846 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 27 | 0.060 |
Why?
|
| Mitogens | 2 | 1996 | 232 | 0.060 |
Why?
|
| Constriction | 1 | 2003 | 181 | 0.060 |
Why?
|
| Chromosome Deletion | 7 | 1989 | 1401 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39050 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3279 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2007 | 2073 | 0.060 |
Why?
|
| Chick Embryo | 4 | 2014 | 982 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 1723 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2005 | 275 | 0.060 |
Why?
|
| Pregnancy | 9 | 2022 | 29144 | 0.060 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1107 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 740 | 0.060 |
Why?
|
| Urban Population | 1 | 2011 | 2021 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 1988 | 658 | 0.060 |
Why?
|
| Long QT Syndrome | 2 | 1999 | 453 | 0.060 |
Why?
|
| Ramipril | 1 | 2023 | 95 | 0.060 |
Why?
|
| Mitochondria | 4 | 2022 | 3520 | 0.060 |
Why?
|
| Reference Values | 4 | 2018 | 4982 | 0.060 |
Why?
|
| alpha-Galactosidase | 2 | 2017 | 57 | 0.060 |
Why?
|
| Hyperaldosteronism | 1 | 1986 | 240 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2024 | 2649 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3107 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2023 | 195 | 0.050 |
Why?
|
| Atrial Function | 2 | 2016 | 107 | 0.050 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2023 | 113 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1730 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 473 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3462 | 0.050 |
Why?
|
| Elasticity | 4 | 2009 | 657 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2018 | 1066 | 0.050 |
Why?
|
| Brain | 6 | 2024 | 26385 | 0.050 |
Why?
|
| Cell Survival | 3 | 2016 | 5882 | 0.050 |
Why?
|
| Protein Binding | 7 | 2017 | 9386 | 0.050 |
Why?
|
| Hybrid Cells | 4 | 1992 | 441 | 0.050 |
Why?
|
| DNA Probes | 4 | 1992 | 560 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2022 | 245 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6538 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2023 | 496 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Hippocampus | 4 | 1999 | 3675 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2715 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1994 | 708 | 0.050 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2002 | 29 | 0.050 |
Why?
|
| Ion Channels | 2 | 1997 | 1056 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3508 | 0.050 |
Why?
|
| Glutamine | 3 | 2018 | 578 | 0.050 |
Why?
|
| Myosin Light Chains | 1 | 2002 | 121 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 217 | 0.050 |
Why?
|
| Nails, Malformed | 1 | 2001 | 32 | 0.050 |
Why?
|
| Quail | 2 | 2018 | 40 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2014 | 5179 | 0.050 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2001 | 72 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2020 | 9849 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 1988 | 1173 | 0.050 |
Why?
|
| Plasmacytoma | 7 | 1980 | 183 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 3002 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2019 | 0.050 |
Why?
|
| Leukemia | 3 | 1986 | 1511 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 1990 | 659 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 3920 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2007 | 555 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2022 | 236 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 4445 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2013 | 19905 | 0.050 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 101 | 0.050 |
Why?
|
| Kidney | 5 | 2017 | 7186 | 0.050 |
Why?
|
| Lymphoma | 5 | 1994 | 1877 | 0.050 |
Why?
|
| Minoxidil | 1 | 2000 | 33 | 0.050 |
Why?
|
| Risk | 3 | 2020 | 9687 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 386 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2001 | 3703 | 0.050 |
Why?
|
| Connexin 43 | 2 | 2017 | 207 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 438 | 0.050 |
Why?
|
| Prognosis | 7 | 2019 | 29063 | 0.050 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 427 | 0.050 |
Why?
|
| Muscle Cells | 2 | 2016 | 197 | 0.050 |
Why?
|
| Ligands | 2 | 2019 | 3282 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2734 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14722 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2003 | 579 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 3 | 1985 | 112 | 0.050 |
Why?
|
| Interleukin-2 | 2 | 1999 | 1904 | 0.050 |
Why?
|
| Globins | 5 | 1978 | 415 | 0.050 |
Why?
|
| Glioma | 1 | 2015 | 3401 | 0.050 |
Why?
|
| Spironolactone | 1 | 2023 | 382 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2002 | 199 | 0.040 |
Why?
|
| Anthracyclines | 1 | 2022 | 288 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 142 | 0.040 |
Why?
|
| Singapore | 1 | 2020 | 295 | 0.040 |
Why?
|
| Atrial Myosins | 1 | 1999 | 3 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2002 | 468 | 0.040 |
Why?
|
| Cosmids | 3 | 1989 | 107 | 0.040 |
Why?
|
| Survival Rate | 5 | 2014 | 12788 | 0.040 |
Why?
|
| Structure-Activity Relationship | 5 | 2007 | 3129 | 0.040 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1386 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2019 | 91 | 0.040 |
Why?
|
| Bundle of His | 1 | 1999 | 87 | 0.040 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 8 | 1993 | 1801 | 0.040 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2000 | 76 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2023 | 1012 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6487 | 0.040 |
Why?
|
| Prospective Studies | 9 | 2019 | 53288 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2022 | 371 | 0.040 |
Why?
|
| Arteries | 1 | 2024 | 1119 | 0.040 |
Why?
|
| Audiometry | 1 | 1999 | 241 | 0.040 |
Why?
|
| Sheep | 1 | 2001 | 1437 | 0.040 |
Why?
|
| Tooth Abnormalities | 1 | 1998 | 54 | 0.040 |
Why?
|
| Azaserine | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 412 | 0.040 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 2 | 2013 | 22 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1202 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2019 | 157 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 1102 | 0.040 |
Why?
|
| Ulna | 1 | 1999 | 133 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2002 | 379 | 0.040 |
Why?
|
| Rats, Inbred Strains | 4 | 1988 | 2186 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 220 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2018 | 118 | 0.040 |
Why?
|
| Risk Factors | 10 | 2020 | 72290 | 0.040 |
Why?
|
| Angiotensin Amide | 1 | 2017 | 4 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2002 | 935 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2003 | 648 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2019 | 434 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.040 |
Why?
|
| Hypophosphatemia, Familial | 1 | 1998 | 34 | 0.040 |
Why?
|
| Viscosity | 3 | 2004 | 328 | 0.040 |
Why?
|
| Necrosis | 2 | 2013 | 1643 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 292 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1999 | 719 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 208 | 0.040 |
Why?
|
| Body Surface Potential Mapping | 1 | 1999 | 238 | 0.040 |
Why?
|
| Neomycin | 4 | 1997 | 88 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 153 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3445 | 0.040 |
Why?
|
| Apocrine Glands | 1 | 1997 | 31 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 1993 | 3768 | 0.040 |
Why?
|
| HLA Antigens | 4 | 2000 | 1381 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 3 | 2002 | 913 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 518 | 0.040 |
Why?
|
| Biopsy | 3 | 2017 | 6756 | 0.040 |
Why?
|
| Computer-Aided Design | 1 | 2019 | 298 | 0.040 |
Why?
|
| Stroke Volume | 4 | 2018 | 5007 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2004 | 1058 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 528 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2017 | 187 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 1613 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2017 | 171 | 0.040 |
Why?
|
| Genitalia | 1 | 1997 | 112 | 0.040 |
Why?
|
| Propylthiouracil | 2 | 2004 | 69 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 1983 | 1607 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1686 | 0.040 |
Why?
|
| Chloride Channels | 1 | 1998 | 227 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2018 | 718 | 0.040 |
Why?
|
| Fluorescence | 1 | 2019 | 751 | 0.040 |
Why?
|
| Causality | 1 | 2023 | 1275 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 1989 | 906 | 0.040 |
Why?
|
| Persia | 1 | 1996 | 6 | 0.040 |
Why?
|
| Face | 1 | 2022 | 994 | 0.040 |
Why?
|
| Cations | 1 | 1997 | 232 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2018 | 961 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1996 | 133 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
| Genetic Engineering | 3 | 2016 | 951 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1998 | 456 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 434 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 3 | 1987 | 33 | 0.030 |
Why?
|
| Kallmann Syndrome | 1 | 1997 | 140 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 500 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 544 | 0.030 |
Why?
|
| Israel | 2 | 2014 | 796 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1679 | 0.030 |
Why?
|
| Protein Folding | 2 | 2014 | 843 | 0.030 |
Why?
|
| Cricetinae | 5 | 1994 | 2472 | 0.030 |
Why?
|
| Deafness | 1 | 2000 | 458 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 302 | 0.030 |
Why?
|
| Cattle | 4 | 1995 | 3922 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12354 | 0.030 |
Why?
|
| Myositis, Inclusion Body | 1 | 1997 | 147 | 0.030 |
Why?
|
| Tetany | 1 | 1994 | 12 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2015 | 399 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 873 | 0.030 |
Why?
|
| Rabbits | 3 | 2008 | 4894 | 0.030 |
Why?
|
| MSX1 Transcription Factor | 3 | 2001 | 53 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15540 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 319 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1355 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2015 | 194 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2011 | 279 | 0.030 |
Why?
|
| Europe | 2 | 2009 | 3339 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 114 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2023 | 2752 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 299 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 1996 | 276 | 0.030 |
Why?
|
| Dimerization | 3 | 2002 | 893 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 2 | 1988 | 534 | 0.030 |
Why?
|
| Coliphages | 5 | 1978 | 120 | 0.030 |
Why?
|
| Arthritis | 1 | 2000 | 659 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 646 | 0.030 |
Why?
|
| Uncertainty | 1 | 2019 | 734 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 417 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1998 | 357 | 0.030 |
Why?
|
| China | 1 | 2020 | 2248 | 0.030 |
Why?
|
| Chimera | 1 | 1996 | 485 | 0.030 |
Why?
|
| Ventricular Function | 2 | 2004 | 416 | 0.030 |
Why?
|
| Proline | 4 | 2003 | 458 | 0.030 |
Why?
|
| Lebanon | 1 | 2015 | 229 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2018 | 596 | 0.030 |
Why?
|
| Chromosome Aberrations | 3 | 1999 | 1813 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2005 | 2575 | 0.030 |
Why?
|
| Parathyroid Hormone | 2 | 1998 | 1801 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2014 | 149 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 2009 | 6314 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 768 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 64 | 0.030 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 6622 | 0.030 |
Why?
|
| Immune Tolerance | 2 | 1993 | 2258 | 0.030 |
Why?
|
| Tibia | 2 | 2013 | 1077 | 0.030 |
Why?
|
| Isometric Contraction | 2 | 2004 | 143 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 126 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 1997 | 0.030 |
Why?
|
| Video Recording | 1 | 2019 | 949 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 2 | 1993 | 113 | 0.030 |
Why?
|
| Alkaptonuria | 1 | 1993 | 13 | 0.030 |
Why?
|
| Actomyosin | 2 | 2005 | 111 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 465 | 0.030 |
Why?
|
| Lactation | 1 | 1996 | 412 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Myositis | 1 | 2016 | 251 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2016 | 2504 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1996 | 854 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2013 | 47 | 0.030 |
Why?
|
| Adipocytes | 1 | 2020 | 1184 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 1996 | 327 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2020 | 852 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 94 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2007 | 3701 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 1996 | 373 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 40 | 0.030 |
Why?
|
| Milk | 1 | 1996 | 450 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 118 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 625 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 1549 | 0.030 |
Why?
|
| Documentation | 1 | 2019 | 871 | 0.030 |
Why?
|
| Motor Activity | 2 | 2013 | 2714 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1997 | 981 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 3 | 1985 | 973 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 147 | 0.030 |
Why?
|
| Hybridomas | 4 | 1990 | 452 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1996 | 695 | 0.030 |
Why?
|
| Myoblasts, Skeletal | 1 | 2013 | 76 | 0.030 |
Why?
|
| Sodium | 3 | 1987 | 1623 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1994 | 258 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 913 | 0.030 |
Why?
|
| Eye Proteins | 2 | 2008 | 646 | 0.030 |
Why?
|
| Cryotherapy | 1 | 1994 | 155 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 462 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 1994 | 192 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 1999 | 1878 | 0.030 |
Why?
|
| Breast | 2 | 1999 | 1969 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2014 | 294 | 0.030 |
Why?
|
| Oocytes | 2 | 1995 | 1187 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 1151 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2014 | 1801 | 0.030 |
Why?
|
| Thymus Gland | 2 | 1988 | 1267 | 0.030 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1992 | 15 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 1996 | 413 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2013 | 11725 | 0.030 |
Why?
|
| Virus Integration | 1 | 2014 | 299 | 0.030 |
Why?
|
| CHO Cells | 2 | 1994 | 1406 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2003 | 1414 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1992 | 68 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 6773 | 0.030 |
Why?
|
| Arginine | 3 | 2004 | 944 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 128 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2005 | 437 | 0.030 |
Why?
|
| Base Pair Mismatch | 1 | 2012 | 97 | 0.030 |
Why?
|
| Dogs | 2 | 1995 | 3912 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 12959 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1990 | 170 | 0.030 |
Why?
|
| Electroporation | 1 | 1994 | 251 | 0.030 |
Why?
|
| Neurons | 4 | 2020 | 9338 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 1993 | 262 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1888 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3206 | 0.030 |
Why?
|
| Genes, Recessive | 2 | 2013 | 641 | 0.030 |
Why?
|
| Bandages | 1 | 1994 | 266 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 2 | 2009 | 54 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2011 | 140 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2019 | 23338 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 2011 | 94 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1850 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 804 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1783 | 0.030 |
Why?
|
| Smell | 1 | 2013 | 244 | 0.030 |
Why?
|
| Meningoencephalitis | 2 | 1989 | 78 | 0.030 |
Why?
|
| Hepacivirus | 1 | 1999 | 1379 | 0.020 |
Why?
|
| Response Elements | 1 | 2013 | 312 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2002 | 1886 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1993 | 368 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 126 | 0.020 |
Why?
|
| Protein Sorting Signals | 2 | 1989 | 281 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2015 | 772 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2003 | 123 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2013 | 276 | 0.020 |
Why?
|
| Papillary Muscles | 2 | 2004 | 203 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3689 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2011 | 72 | 0.020 |
Why?
|
| Mothers | 1 | 2022 | 2165 | 0.020 |
Why?
|
| Cell Count | 1 | 2015 | 1856 | 0.020 |
Why?
|
| Graft vs Host Reaction | 1 | 1991 | 104 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1161 | 0.020 |
Why?
|
| Biological Transport | 1 | 1995 | 2118 | 0.020 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1990 | 16 | 0.020 |
Why?
|
| Molecular Weight | 5 | 1987 | 2255 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1990 | 363 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2958 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1997 | 1178 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2010 | 51 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1994 | 957 | 0.020 |
Why?
|
| Potassium | 2 | 2002 | 1336 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1999 | 1422 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 1205 | 0.020 |
Why?
|
| Knee Prosthesis | 1 | 1994 | 425 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 2 | 1980 | 2 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2000 | 2356 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2010 | 164 | 0.020 |
Why?
|
| Autoimmune Diseases | 2 | 2001 | 2133 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 895 | 0.020 |
Why?
|
| Infertility, Male | 1 | 1993 | 409 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Mice, Inbred AKR | 2 | 1986 | 107 | 0.020 |
Why?
|
| Receptors, Melanocortin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 503 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3798 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1994 | 1092 | 0.020 |
Why?
|
| RNA, Viral | 2 | 1975 | 2902 | 0.020 |
Why?
|
| Synapses | 1 | 1999 | 1728 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 235 | 0.020 |
Why?
|
| Digoxin | 1 | 1990 | 250 | 0.020 |
Why?
|
| Herpes Zoster | 2 | 1989 | 264 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.020 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 240 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2021 | 77449 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 4479 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 299 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8480 | 0.020 |
Why?
|
| Lateral Line System | 1 | 2008 | 12 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2013 | 965 | 0.020 |
Why?
|
| Placenta | 1 | 1998 | 1698 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 457 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 893 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2001 | 2020 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2009 | 129 | 0.020 |
Why?
|
| Teratoma | 2 | 1989 | 395 | 0.020 |
Why?
|
| Organ Specificity | 2 | 2003 | 2008 | 0.020 |
Why?
|
| Calcimycin | 1 | 1988 | 222 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1998 | 10943 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 684 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 330 | 0.020 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4456 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1999 | 1591 | 0.020 |
Why?
|
| Neoplasms, Experimental | 5 | 1980 | 1276 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2013 | 671 | 0.020 |
Why?
|
| Azacitidine | 1 | 1990 | 347 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2009 | 142 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1988 | 147 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 635 | 0.020 |
Why?
|
| Filtration | 1 | 2009 | 234 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1126 | 0.020 |
Why?
|
| Incidence | 2 | 2019 | 20947 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 1985 | 1116 | 0.020 |
Why?
|
| Killer Cells, Natural | 2 | 1988 | 2133 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2009 | 214 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5917 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 783 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2016 | 2740 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 1996 | 3036 | 0.020 |
Why?
|
| Skeleton | 1 | 2007 | 30 | 0.020 |
Why?
|
| Isoleucine | 1 | 2007 | 112 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 1989 | 204 | 0.020 |
Why?
|
| Substrate Cycling | 1 | 2007 | 8 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 712 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 1150 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 827 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1987 | 181 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2499 | 0.020 |
Why?
|
| Cell Movement | 2 | 2014 | 5217 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 770 | 0.020 |
Why?
|
| Biological Evolution | 4 | 1982 | 1076 | 0.020 |
Why?
|
| Pyrazines | 1 | 2013 | 1230 | 0.020 |
Why?
|
| Tetracycline | 1 | 2007 | 214 | 0.020 |
Why?
|
| Antibodies | 2 | 2013 | 2460 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1993 | 1171 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 557 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 281 | 0.020 |
Why?
|
| Escherichia coli | 3 | 1980 | 4217 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9146 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1987 | 349 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1994 | 1486 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2107 | 0.020 |
Why?
|
| Brazil | 1 | 2011 | 1270 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1988 | 234 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1986 | 50 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 279 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15295 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 6993 | 0.020 |
Why?
|
| Social Behavior | 1 | 2013 | 1127 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 2 | 2002 | 964 | 0.020 |
Why?
|
| Chromosome Banding | 3 | 1992 | 278 | 0.020 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1986 | 64 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 35421 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1839 | 0.020 |
Why?
|
| Optical Tweezers | 1 | 2007 | 79 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 1994 | 980 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2008 | 277 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2886 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1880 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1547 | 0.020 |
Why?
|
| Catheter Ablation | 2 | 2016 | 2758 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 1993 | 4776 | 0.020 |
Why?
|
| Mitochondrial Myopathies | 1 | 2006 | 47 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 909 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 186 | 0.020 |
Why?
|
| Biotransformation | 1 | 2006 | 168 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1994 | 1838 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2149 | 0.020 |
Why?
|
| Complement C2 | 1 | 1985 | 72 | 0.020 |
Why?
|
| Genetic Code | 2 | 1983 | 154 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 285 | 0.020 |
Why?
|
| Complement Factor B | 1 | 1985 | 72 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 361 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 372 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1991 | 1063 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 5987 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 63114 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3128 | 0.020 |
Why?
|
| Poly A | 2 | 1983 | 185 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2006 | 119 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 474 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 838 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1881 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1985 | 176 | 0.020 |
Why?
|
| Ribonucleases | 3 | 1994 | 287 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 641 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12026 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4034 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 661 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1989 | 1263 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 1020 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 185 | 0.020 |
Why?
|
| Patient Participation | 1 | 2014 | 1457 | 0.020 |
Why?
|
| Ribonucleotides | 2 | 1975 | 117 | 0.020 |
Why?
|
| Regeneration | 1 | 2014 | 1485 | 0.020 |
Why?
|
| Natriuretic Agents | 1 | 1984 | 25 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 1985 | 90 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1988 | 2104 | 0.020 |
Why?
|
| Knee Joint | 1 | 1994 | 1680 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2171 | 0.020 |
Why?
|
| Autoradiography | 1 | 1985 | 745 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1985 | 829 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2000 | 6077 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 2085 | 0.020 |
Why?
|
| Sex Factors | 3 | 2008 | 10397 | 0.020 |
Why?
|
| Venezuela | 1 | 2004 | 73 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 752 | 0.020 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2005 | 60 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 1240 | 0.020 |
Why?
|
| Chlorides | 1 | 1987 | 667 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 2 | 1983 | 517 | 0.020 |
Why?
|
| Thyroxine | 1 | 1988 | 667 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1984 | 31 | 0.020 |
Why?
|
| PAX9 Transcription Factor | 1 | 2003 | 13 | 0.020 |
Why?
|
| Lymphocyte Cooperation | 1 | 1984 | 112 | 0.020 |
Why?
|
| HLA-DR Antigens | 2 | 1983 | 645 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 1996 | 4560 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 3336 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2022 | 12720 | 0.010 |
Why?
|
| Learning | 1 | 2013 | 1713 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 3587 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 123 | 0.010 |
Why?
|
| Procainamide | 1 | 2003 | 61 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2007 | 570 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 712 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 420 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2459 | 0.010 |
Why?
|
| Dermis | 1 | 2005 | 207 | 0.010 |
Why?
|
| Muscle Strength | 1 | 2008 | 592 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1987 | 634 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1997 | 11366 | 0.010 |
Why?
|
| Epilepsy | 1 | 2019 | 3310 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1072 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1983 | 134 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
| Base Composition | 1 | 1983 | 293 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2005 | 235 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 759 | 0.010 |
Why?
|
| Radiography | 2 | 2005 | 7023 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 783 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2013 | 2948 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2003 | 149 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1989 | 804 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1984 | 302 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 93 | 0.010 |
Why?
|
| Gestational Age | 1 | 1991 | 3493 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4149 | 0.010 |
Why?
|
| DNA Repair | 1 | 2012 | 2046 | 0.010 |
Why?
|
| Fibula | 1 | 2005 | 269 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 433 | 0.010 |
Why?
|
| Cholesterol | 1 | 2011 | 2917 | 0.010 |
Why?
|
| Introns | 2 | 1997 | 991 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7279 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 905 | 0.010 |
Why?
|
| Cytoplasm | 2 | 1984 | 1539 | 0.010 |
Why?
|
| Graft Survival | 1 | 1993 | 3737 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 140 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2925 | 0.010 |
Why?
|
| Hemolysis | 1 | 1984 | 420 | 0.010 |
Why?
|
| Trophoblasts | 1 | 1983 | 215 | 0.010 |
Why?
|
| Gene Conversion | 1 | 1982 | 71 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 697 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2575 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 89 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1985 | 436 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2689 | 0.010 |
Why?
|
| Antigens, Neoplasm | 3 | 1987 | 1988 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1572 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 595 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4397 | 0.010 |
Why?
|
| Drug Resistance | 2 | 1984 | 1609 | 0.010 |
Why?
|
| Anthropometry | 1 | 2006 | 1350 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2000 | 20 | 0.010 |
Why?
|
| Antibody Diversity | 1 | 1981 | 74 | 0.010 |
Why?
|
| Disulfides | 3 | 1987 | 457 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1987 | 1261 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1984 | 748 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1988 | 1951 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2003 | 437 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 436 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1991 | 156 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1987 | 1504 | 0.010 |
Why?
|
| Pertussis Toxin | 2 | 1991 | 178 | 0.010 |
Why?
|
| Phosphorylcholine | 1 | 1981 | 162 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2005 | 602 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 786 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13989 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2019 | 6882 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 2002 | 455 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2003 | 546 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2003 | 844 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2001 | 215 | 0.010 |
Why?
|
| Lamins | 1 | 1999 | 36 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2000 | 95 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1413 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2015 | 3481 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6196 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Water | 2 | 2002 | 1395 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 2002 | 449 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 1590 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2208 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2000 | 402 | 0.010 |
Why?
|
| Data Collection | 1 | 2009 | 3341 | 0.010 |
Why?
|
| Paralysis | 1 | 2001 | 247 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
| Choline | 1 | 1981 | 493 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1984 | 914 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1988 | 1177 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 874 | 0.010 |
Why?
|
| Mice, Congenic | 1 | 1999 | 99 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4297 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3147 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 1978 | 143 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1983 | 679 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1999 | 229 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2004 | 1462 | 0.010 |
Why?
|
| RNA, Neoplasm | 2 | 1980 | 769 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2006 | 1194 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 2 | 1989 | 63 | 0.010 |
Why?
|
| Adenosine | 1 | 2003 | 825 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1998 | 39 | 0.010 |
Why?
|
| Disease Susceptibility | 2 | 1996 | 1782 | 0.010 |
Why?
|
| Subacute Sclerosing Panencephalitis | 2 | 1988 | 24 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1379 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1978 | 109 | 0.010 |
Why?
|
| Melanoma | 1 | 2016 | 5510 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8301 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1994 | 1799 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 1869 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 1999 | 293 | 0.010 |
Why?
|
| Weight Loss | 2 | 2001 | 2622 | 0.010 |
Why?
|
| Afghanistan | 1 | 1997 | 81 | 0.010 |
Why?
|
| Iraq | 1 | 1997 | 92 | 0.010 |
Why?
|
| United States | 3 | 2016 | 69872 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 2011 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3864 | 0.010 |
Why?
|
| Spermine | 1 | 1997 | 70 | 0.010 |
Why?
|
| Multiple Sclerosis | 2 | 1990 | 3079 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 655 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 192 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1998 | 331 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 2252 | 0.010 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 35 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1097 | 0.010 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 1996 | 70 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 2 | 1987 | 31 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1999 | 585 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1256 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 914 | 0.010 |
Why?
|
| Isoenzymes | 2 | 1999 | 1726 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3086 | 0.010 |
Why?
|
| France | 1 | 1997 | 517 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1997 | 596 | 0.010 |
Why?
|
| Body Weight | 2 | 2002 | 4669 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13408 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1988 | 648 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 1996 | 286 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1997 | 318 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9856 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1995 | 130 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 206 | 0.010 |
Why?
|
| Serine | 2 | 1975 | 826 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1989 | 3143 | 0.010 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1993 | 13 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4251 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1999 | 587 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 2000 | 950 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1998 | 845 | 0.010 |
Why?
|
| Cytoplasmic Granules | 2 | 1986 | 610 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 1984 | 94 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1117 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1997 | 1682 | 0.010 |
Why?
|
| Ionomycin | 1 | 1993 | 109 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 1360 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15076 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 1998 | 465 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1993 | 248 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1995 | 288 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1994 | 473 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 1987 | 547 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1989 | 4262 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1985 | 964 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 1185 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1997 | 824 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 1460 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 2225 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1085 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2327 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 821 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1997 | 1767 | 0.010 |
Why?
|
| Canada | 1 | 1997 | 2065 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 258 | 0.010 |
Why?
|
| Microtubules | 1 | 1997 | 1090 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1991 | 159 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1940 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 673 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1899 | 0.010 |
Why?
|
| Pancreatic Diseases | 1 | 1993 | 350 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 97 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20822 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7785 | 0.010 |
Why?
|
| Electrophoresis | 2 | 1986 | 240 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1991 | 449 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 1984 | 7880 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1991 | 1101 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1990 | 254 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1991 | 471 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1969 | 52 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1988 | 31 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 625 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 598 | 0.010 |
Why?
|
| Dendritic Cells | 2 | 1994 | 2725 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1969 | 170 | 0.010 |
Why?
|
| Isoantigens | 1 | 1991 | 567 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1980 | 3589 | 0.000 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1989 | 262 | 0.000 |
Why?
|
| Spleen | 1 | 1994 | 2362 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1969 | 308 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1999 | 3176 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3760 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1969 | 418 | 0.000 |
Why?
|
| Probability | 1 | 1993 | 2505 | 0.000 |
Why?
|
| tau Proteins | 1 | 1997 | 1868 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 184 | 0.000 |
Why?
|
| Lymphocytosis | 1 | 1988 | 119 | 0.000 |
Why?
|
| Range of Motion, Articular | 1 | 1994 | 1578 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 11031 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1987 | 322 | 0.000 |
Why?
|
| Islets of Langerhans | 1 | 1993 | 1352 | 0.000 |
Why?
|
| Stroke | 1 | 2009 | 9981 | 0.000 |
Why?
|
| Karyotyping | 1 | 1988 | 1243 | 0.000 |
Why?
|
| Rats, Mutant Strains | 1 | 1985 | 70 | 0.000 |
Why?
|
| Rhodopsin | 1 | 1986 | 203 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1986 | 919 | 0.000 |
Why?
|
| Equipment Design | 1 | 1994 | 3582 | 0.000 |
Why?
|
| Protein Multimerization | 1 | 1990 | 970 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1994 | 2530 | 0.000 |
Why?
|
| Corticosterone | 1 | 1986 | 310 | 0.000 |
Why?
|
| Fibrin | 1 | 1987 | 506 | 0.000 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1984 | 17 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1993 | 1451 | 0.000 |
Why?
|
| Antigens | 1 | 1990 | 1466 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1984 | 179 | 0.000 |
Why?
|
| Rodent Diseases | 1 | 1984 | 57 | 0.000 |
Why?
|
| Neprilysin | 1 | 1987 | 439 | 0.000 |
Why?
|
| HLA-A2 Antigen | 1 | 1984 | 213 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 2000 | 4371 | 0.000 |
Why?
|
| Thymoma | 1 | 1986 | 186 | 0.000 |
Why?
|
| Metaphase | 1 | 1984 | 151 | 0.000 |
Why?
|
| Trinitrobenzenes | 1 | 1983 | 46 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1983 | 15 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1994 | 5974 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1994 | 1643 | 0.000 |
Why?
|
| Kidney Glomerulus | 1 | 1986 | 697 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1991 | 1900 | 0.000 |
Why?
|
| Lactoylglutathione Lyase | 1 | 1983 | 16 | 0.000 |
Why?
|
| Muscular Dystrophy, Oculopharyngeal | 1 | 1963 | 8 | 0.000 |
Why?
|
| Haptens | 1 | 1983 | 166 | 0.000 |
Why?
|
| Thymus Neoplasms | 1 | 1986 | 268 | 0.000 |
Why?
|
| Retina | 1 | 1994 | 2616 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2967 | 0.000 |
Why?
|
| Lymphopenia | 1 | 1985 | 285 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1983 | 565 | 0.000 |
Why?
|
| Progesterone | 1 | 1986 | 776 | 0.000 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1980 | 47 | 0.000 |
Why?
|
| Inflammation | 1 | 2001 | 10638 | 0.000 |
Why?
|
| Skin | 1 | 1994 | 4364 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1984 | 456 | 0.000 |
Why?
|
| Eyelids | 1 | 1963 | 265 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1980 | 110 | 0.000 |
Why?
|
| Surface Properties | 1 | 1983 | 1184 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1993 | 4386 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 986 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1985 | 1402 | 0.000 |
Why?
|
| Trypsin | 1 | 1980 | 511 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1991 | 4397 | 0.000 |
Why?
|
| Analgesics, Opioid | 1 | 1994 | 3674 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 1129 | 0.000 |
Why?
|
| Mitosis | 1 | 1983 | 1208 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1963 | 605 | 0.000 |
Why?
|
| Translocation, Genetic | 1 | 1983 | 1420 | 0.000 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1977 | 87 | 0.000 |
Why?
|
| Lysogeny | 1 | 1973 | 67 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1973 | 104 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1973 | 223 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1973 | 682 | 0.000 |
Why?
|
| DNA Replication | 1 | 1977 | 1399 | 0.000 |
Why?
|
| Phosphoglucomutase | 1 | 1969 | 6 | 0.000 |
Why?
|
| Phosphorylase Kinase | 1 | 1969 | 10 | 0.000 |
Why?
|
| Plasma Volume | 1 | 1969 | 36 | 0.000 |
Why?
|
| Myoglobinuria | 1 | 1969 | 23 | 0.000 |
Why?
|
| Malate Dehydrogenase | 1 | 1969 | 41 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1969 | 115 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1969 | 424 | 0.000 |
Why?
|
| Pyruvate Kinase | 1 | 1969 | 189 | 0.000 |
Why?
|
| Creatine Kinase | 1 | 1969 | 694 | 0.000 |
Why?
|
| Muscles | 1 | 1969 | 1614 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1979 | 5181 | 0.000 |
Why?
|
| Alcoholism | 1 | 1969 | 1906 | 0.000 |
Why?
|